AngioDynamics Inc. (ANGO)

Business: AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access.

IPO Date: 27-May-2004

CEO, Pres & Director: Mr. James C. Clemmer

Exec. VP & CFO: Mr. Stephen A. Trowbridge

Listing: NASDAQ: ANGO

Country: United States

Headquarters: Latham, NY

Website: https://www.angiodynamics.com

Market cap: $757.76 Mln

Revenue (TTM): $306.06 Mln

Earnings (TTM): $-39.75 Mln

Cash: $23.89 Mln

Total Debt: $25.00 Mln

Insider's Holding: 4.56%

Liquidity: Low

52 Week range: $17.57 - 32.00

Shares outstanding: 38,780,100

10 Years Aggregate:

• CFO: $279.13 Mln
• EBITDA: $10.91 Mln
• Net Profit: $-237.61 Mln